By Siddhi Mahatole and Puyaan Singh (Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

There are many different things that can cause memory problems that can mimic Alzheimer’s Disease, and appropriately ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with ...

The Alzheimer’s Foundation of America (AFA) is offering some tips for families to create a dementia-friendly Fourth of July.

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

Researchers have developed a blood test that detects Alzheimer's biomarkers at single-molecule levels, enabling earlier, ...

Shares of INmune Bio ( NASDAQ: INMB) dropped on Monday after the company did not achieve the main goal in a mid-stage trial ...